{"id":18617,"date":"2021-09-28T11:49:00","date_gmt":"2021-09-28T11:49:00","guid":{"rendered":"https:\/\/haberglobal.com.tr\/gundem\/manisa-celal-bayar-universitesinin-3-doz-asi-arastirma-sonuclari-aciklandi-biontech-mi-sinovac-mi-135359"},"modified":"2021-09-28T11:49:00","modified_gmt":"2021-09-28T11:49:00","slug":"manisa-celal-bayar-universitesinin-3-doz-asi-arastirma-sonuclari-aciklandi-biontech-mi-sinovac-mi","status":"publish","type":"post","link":"https:\/\/istanbulchannel.net\/index.php\/2021\/09\/28\/manisa-celal-bayar-universitesinin-3-doz-asi-arastirma-sonuclari-aciklandi-biontech-mi-sinovac-mi\/","title":{"rendered":"Manisa Celal Bayar \u00dcniversitesi’nin 3. doz a\u015f\u0131 ara\u015ft\u0131rma sonu\u00e7lar\u0131 a\u00e7\u0131kland\u0131: Biontech mi, Sinovac m\u0131?"},"content":{"rendered":"

<\/p>\n

<\/div>\n
\n

Yay\u0131nlanma: <\/span>

\n

Manisa<\/a> Celal Bayar \u00dcniversitesi’nden yap\u0131lan yaz\u0131l\u0131 a\u00e7\u0131klamaya g\u00f6re, MCB\u00dc Bilimsel Ara\u015ft\u0131rma Projeleri Birimi, T\u00fcrkiye\u2019de uygulanan iki doz Sinovac SARS-CoV-2 inaktif a\u015f\u0131s\u0131n\u0131n 6. ay takip sonu\u00e7lar\u0131 ile 3. doz sonras\u0131 ortaya \u00e7\u0131kan etkililik sonu\u00e7lar\u0131n\u0131 ara\u015ft\u0131rd\u0131.<\/p>\n

\u00c7al\u0131\u015fman\u0131n MCB\u00dc T\u0131p Fak\u00fcltesi T\u0131bbi Mikrobiyoloji, Halk Sa\u011fl\u0131\u011f\u0131 ve Enfeksiyon Hastal\u0131klar\u0131 Ana Bilim Dal\u0131 \u00f6\u011fretim elemanlar\u0131 taraf\u0131ndan y\u00fcr\u00fct\u00fcld\u00fc\u011f\u00fc belirtildi.<\/p>\n

\u00c7al\u0131\u015fmaya 1053 g\u00f6n\u00fcll\u00fc sa\u011fl\u0131k \u00e7al\u0131\u015fan\u0131n\u0131n kat\u0131ld\u0131\u011f\u0131 aktar\u0131lan a\u00e7\u0131klamada, a\u015f\u0131 sonras\u0131 \u00e7al\u0131\u015fma grubundakilerin hastalanma s\u0131kl\u0131\u011f\u0131 ve a\u015f\u0131n\u0131n olu\u015fturdu\u011fu antikor d\u00fczeylerinin ara\u015ft\u0131r\u0131ld\u0131\u011f\u0131 kaydedildi.<\/p>\n

3. DOZ SONRASI ETK\u0130LER: “BIONTECH B\u00dcY\u00dcK \u00dcST\u00dcNL\u00dcK G\u00d6STERD\u0130”<\/strong><\/h2>\n

A\u00e7\u0131klamada, iki doz CoronaVac a\u015f\u0131 sonras\u0131 6. ay sonu\u00e7lar\u0131 ile 3. doz sonras\u0131 ortaya \u00e7\u0131kan etkilere ili\u015fkin \u015fu ifadeler kullan\u0131ld\u0131:<\/p>\n

“Sadece 2 doz CoronaVac olanlarda antikor koruyuculuk d\u00fczeyi, ikinci a\u015f\u0131dan sonra \u00fc\u00e7\u00fcnc\u00fc ayda y\u00fczde 56\u2019ya d\u00fc\u015fm\u00fc\u015ft\u00fcr. Bu veri 3. doz a\u015f\u0131laman\u0131n yerinde bir karar oldu\u011funu kan\u0131tlam\u0131\u015ft\u0131r. \u00dc\u00e7\u00fcnc\u00fc doz a\u015f\u0131 tercihi ne olursa olsun, \u00fc\u00e7 doz a\u015f\u0131y\u0131 olan bireylerin t\u00fcm\u00fc koruyucu antikor d\u00fczeylerine ula\u015fm\u0131\u015flard\u0131r. \u00dc\u00e7\u00fcnc\u00fc doz a\u015f\u0131da uygulanan BioNTech a\u015f\u0131s\u0131, \u00fc\u00e7\u00fcnc\u00fc doz CoronaVac (Sinovac) a\u015f\u0131s\u0131na g\u00f6re koruyuculukta (gerek antikor d\u00fczeyi, gerekse hastalanma durumu a\u00e7\u0131s\u0131ndan) belirgin \u00fcst\u00fcnl\u00fck g\u00f6stermi\u015ftir. \u00dc\u00e7\u00fcnc\u00fc dozu BioNTech olanlar\u0131n antikor d\u00fczeyi, kat\u0131l\u0131mc\u0131lar\u0131n y\u00fczde 95\u2019inde \u00f6l\u00e7\u00fclebilen maksimum titrenin \u00fcst\u00fcndedir.<\/p>\n

“3’TE UYGULANAN BIONTECH SONRASI 4. DOZ BIONTECH \u0130\u00c7\u0130N HEN\u00dcZ ERKEN OLAB\u0130L\u0130R”<\/strong><\/h2>\n

Bu durumda 2 doz CoronaVac ve ilave 1 doz BioNTech sonras\u0131 4. doz BioNTech a\u015f\u0131s\u0131 uygulanmas\u0131n\u0131n hen\u00fcz erken oldu\u011fu d\u00fc\u015f\u00fcn\u00fclebilir. Olas\u0131 2. doz BioNTech a\u015f\u0131s\u0131n\u0131n (4. dozun) ne zaman yap\u0131lmas\u0131 gerekti\u011fi sorusuna, 3. doz uygulamas\u0131 sonras\u0131 3. ve 6. ay sonu\u00e7lar\u0131 elde edildi\u011finde yan\u0131t verilebilir. 3. a\u015f\u0131dan sonra ge\u00e7en d\u00f6nemde hastalanan 44 \u00e7al\u0131\u015fandan hi\u00e7biri hastaneye yat\u0131r\u0131lmam\u0131\u015f, hastal\u0131\u011f\u0131 ayakta ge\u00e7irmi\u015flerdir.”<\/p>\n

Kaynak: AA<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

Manisa Celal Bayar \u00dcniversitesi (MCB\u00dc) T\u0131p Fak\u00fcltesi Hafsa Sultan Hastanesi’nde g\u00f6revli 1053 sa\u011fl\u0131k \u00e7al\u0131\u015fan\u0131 \u00fczerinde yap\u0131lan ara\u015ft\u0131rmada, \u00fc\u00e7 doz a\u015f\u0131…<\/p>\n","protected":false},"author":2,"featured_media":18618,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,13],"tags":[],"class_list":["post-18617","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gundem","category-saglik"],"_links":{"self":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/18617","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/comments?post=18617"}],"version-history":[{"count":0,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/18617\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media\/18618"}],"wp:attachment":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media?parent=18617"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/categories?post=18617"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/tags?post=18617"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}